PCI Biotech: Employee share option scheme
02. September 2024 01:53 ET
|
PCI Biotech Holding ASA
Oslo, 2 September 2024 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the...
PCI Biotech first half 2024 interim results
28. August 2024 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 28 August 2024 – PCI Biotech (OSE: PCIB), today announces its interim first half 2024 results. Please find enclosed the interim report and presentation.Highlights review ...
PCI Biotech: Invitation to first half interim 2024 results presentation
23. August 2024 03:36 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2024 interim report on Wednesday 28 August 2024, 08:30am – 09:00am CEST (local...
Minutes of Annual General Meeting 2024
24. Mai 2024 06:30 ET
|
PCI Biotech Holding ASA
Oslo, 24 May 2024. The Annual General Meeting in PCI Biotech Holding ASA took place today, 24 May 2024. All the matters on the agenda were approved and the minutes of the Annual General Meeting...
Disclosure of voting rights for Chair of the Board
23. Mai 2024 03:03 ET
|
PCI Biotech Holding ASA
Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors. Hans Peter Bøhn is chair of PCI...
PCI Biotech Holding ASA - Notice of Annual General Meeting 2024
03. Mai 2024 04:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway 3 May 2024 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 24 May 2024 at 10:00am (CEST). The...
PCI Biotech Holding ASA - Annual Report 2023
26. April 2024 02:08 ET
|
PCI Biotech Holding ASA
Oslo, Norway, April 26, 2024.The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European...
PCI Biotech second half 2023 interim results
14. Februar 2024 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 14 February 2024 – PCI Biotech (OSE: PCIB), today announces its interim second half 2023 results. Please find enclosed the interim report and presentation. Highlights review ...
PCI Biotech: Invitation to second half interim 2023 results presentation
12. Februar 2024 03:26 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 12 February 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's second half 2023 interim report on Wednesday 14 February 2024, 08:30am – 09:30am CET (local...
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
13. Oktober 2023 04:17 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The...